[TOVX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[TOVX] Theriva Biologics, Inc.
Announcement Date
30-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -156.69%
YoY- -30.76%
Quarter Report
TOVX's Result
TOVX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,111 -5,150 -3,689 -10,930 -8,489 -7,507 -4,910 -13.11%
Tax -8 -30 -640 5,080 -803 -4,876 0 -
NP -2,103 -5,120 -3,680 -10,922 -8,353 -6,774 -4,910 -13.16%
Tax Rate - - - - - - - -
Total Cost 2,103 5,120 3,680 10,922 8,353 6,774 4,910 -13.16%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -1.08 -3.05 -9.14 -29.80 -31.97 -27.58 -29.40 -42.31%
EPS Diluted -1.08 -3.05 -9.14 -29.80 -31.97 -27.07 -29.40 -42.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.